Callistemon citrinus (Callistemon citrinus): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Callistemon citrinus work as an antimicrobial?

Callistemon citrinus exerts antimicrobial effects primarily through its volatile oil compounds, particularly 1,8-cineole and terpinen-4-ol. These compounds disrupt bacterial cell membranes and interfere with microbial enzyme systems. The herb also contains quercetin and tannins, which contribute anti-inflammatory and astringent properties. Research suggests these compounds work synergistically to inhibit growth of various bacteria and fungi. Evidence Level C indicates preliminary research support, primarily from in vitro and animal studies rather than large-scale human clinical trials.

Does Callistemon citrinus interact with any medications?

Limited research exists on specific drug interactions for Callistemon citrinus. Due to its 1,8-cineole content, it may theoretically affect liver enzyme systems that metabolize medications. Patients taking anticoagulants should exercise caution, as anti-inflammatory compounds might influence bleeding parameters. Those on diabetes medications should monitor blood sugar closely, as some constituents may affect glucose metabolism. Always consult a healthcare provider before combining herbal remedies with prescription medications, particularly blood thinners, antidiabetics, or drugs metabolized by the liver.

What is the recommended dosage for Callistemon citrinus tea?

The traditional adult dosage for Callistemon citrinus is approximately 2 grams of dried leaf prepared as a tea, consumed up to three times daily. To prepare, steep the dried leaves in boiling water for 10-15 minutes, then strain before drinking. This dosage is based on traditional use and limited clinical observation rather than standardized clinical trials. Dosage may vary depending on the specific condition being addressed. Consult a qualified herbalist or healthcare practitioner for personalized recommendations, especially for prolonged use beyond two weeks.

Is Callistemon citrinus safe during pregnancy and breastfeeding?

Callistemon citrinus is considered unsafe during pregnancy and should be avoided. The essential oil compounds, particularly 1,8-cineole, may stimulate uterine contractions and potentially affect fetal development. There is insufficient evidence regarding safety during breastfeeding, so avoidance is recommended. Women who are pregnant, planning pregnancy, or breastfeeding should consult their healthcare provider before using any herbal preparations. Traditional use does not establish safety for these populations, and the precautionary principle applies given the lack of clinical safety data.

What are the traditional uses of Callistemon citrinus in Aboriginal medicine?

Callistemon citrinus, commonly known as crimson bottlebrush, has a long history in Australian Aboriginal and folk medicine. Traditional applications include treating respiratory conditions such as coughs and bronchitis, using the leaves as a tea or inhalant. The herb was applied topically for skin infections, wounds, and as a general antiseptic wash. Fever reduction and anti-inflammatory applications were also common. These uses align with modern research identifying antimicrobial and anti-inflammatory compounds in the plant. Evidence Level C supports these traditional applications through preliminary laboratory studies.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Callistemon citrinus is an ornamental shrub native to Australia with documented antimicrobial, antioxidant, and anti-inflammatory properties [PMID: 32087316, 38435992, 34028046].

Background

Callistemon citrinus (also known as bottlebrush) is an evergreen shrub native to Australia [PMID: 30923945, 30754367]. It is widely used as an ornamental plant globally, including in Mexico [PMID: 30923945, 31241699].

Active compounds

Major compounds include 1,8-cineole (eucalyptol), alpha-pinene, limonene, alpha-terpineol, p-cymene, and alpha-phellandrene [PMID: 30923945, 37728015, 34028046]. Other bioactive constituents include terpenoids, phenolic acids, flavonoids, gallic acid, ellagic acid, p-coumaric acid, and anthocyanins such as cyanidin-3,5-O-diglucoside and peonidin-3,5-O-diglucoside [PMID: 37765149, 41590633, 32824448]. Specific meroterpenoids (callistrilones L, O, and P) and the triterpene lactone ursenolide have also been isolated [PMID: 32631550, 32573227, 32865330].

Mechanism of action

The herb induces antioxidant enzymes and exhibits anti-inflammatory effects by reducing the activity of enzymes such as COX-2, 5-LOX, and MPO [PMID: 34435594, 39456515]. In pancreatic cancer cells (PANC-1), certain compounds like ursenolide inhibit the unfolded protein response by suppressing GRP78 and GRP94 under nutrient starvation [PMID: 32865330]. It also demonstrates the ability to inhibit inducible nitric oxide synthase (iNOS) activity [PMID: 33845184].

Clinical evidence

Evidence DMethicillin-resistant Staphylococcus aureus (MRSA) biofilm

Crude extracts and isolated compounds act as inhibitors of biofilm formation [PMID: 32087316]

Evidence DIndomethacin-induced gastric ulcers (obese rats)

Ethanolic leaf extract (250 mg/kg) produced a reduction in gastric lesions and inflammatory enzyme activities [PMID: 38435992]

Evidence D1,2-dimethylhydrazine-induced colon cancer (rats)

Daily oral dose of 250 mg/kg showed chemopreventive efficacy by reducing colon tumors and aberrant crypt foci [PMID: 30923945, 34435594]

Evidence DOxidative stress and inflammation (obese rats)

Leaf extract and phytosomes reduced oxidative stress and inflammation in the liver, heart, and brain [PMID: 39456515, 40867573]

Evidence DPancreatic cancer (PANC-1 cell line)

Leaf extracts and isolated meroterpenoids exhibit preferential cytotoxicity against cells under nutrient starvation [PMID: 32631550, 32573227]

Evidence D

Safety & adverse effects

Acute toxicity studies in rats using single oral doses of ethanol extract (100-4000 mg/kg) and subacute toxicity studies (1000 mg/kg/day for 28 days) were conducted [PMID: 35938503]. Allium cepa assays showed negligible genotoxicity [PMID: 34028046].

Evidence summary

The current evidence is based entirely on preclinical studies, including in vitro cell lines and in vivo rodent models (rats and mice). There are no human clinical trials available.

PubMed sources

1.PMID: 32087316 (2020) — Callistemon citrinus bioactive metabolites as new inhibitors of methicillin-resistant Staphylococcus aureus biofilm formation. · Journal of ethnopharmacology
2.PMID: 39456515 (2024) — Role of Callistemon citrinus Leaf Phytosomes Against Oxidative Stress and Inflammation in Rats Fed with a High-Fat-Fructose Diet. · Antioxidants (Basel, Switzerland)
3.PMID: 38435992 (2024) — Use of Callistemon citrinus as a gastroprotective and anti-inflammatory agent on indomethacin-induced gastric ulcers in obese rats. · PeerJ
4.PMID: 38869599 (2024) — Comparative Study of Callistemon citrinus (Bottlebrush) and Punica granatum (Pomegranate) Extracts for Sustainable Synthesis of Silver Nanoparticles and Their Oral Antimicrobial Efficacy. · Nanomaterials (Basel, Switzerland)
5.PMID: 34435594 (2021)

Callistemon citrinus

Sources & Citations

Calculate a safe dose of Callistemon citrinus

Copal

Entada Africana

Reindeer Lichen

Frequently asked questions

Summary

Background

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources

Callistemon citrinus

Sources & Citations

Calculate a safe dose of Callistemon citrinus

Related Herbs

Copal

Entada Africana

Reindeer Lichen

Frequently asked questions

Summary

Background

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources